The All India Institute of Medical Sciences in Delhi has started screening children aged between 12-18 years for clinical trials of India's indigenous COVID-19 vaccine- Bharat Biotech's Covaxin.
The Delhi government ordered all private hospitals and nursing homes to ensure that the Covaxin doses are used only to vaccinate those people from the 18-44 age group who are eligible for receiving the second dose in June.
EXAMIANS